Home > Healthcare > Medical Devices > Surgical Devices > Embolic Protection Devices Market

Embolic Protection Devices Market Share

Report ID: GMI2417
Published Date: Jul 2023
Report Format: PDF

Download Free Sample

Embolic Protection Devices Market Share

Some of the major players operating in the embolic protection devices market are

Transverse Medical, Inc.
Abbott Laboratories
Cardinal Health
Allium Medica
Edwards Lifesciences Corporation
W. L. Gore & Associates (Gore Medical)
Contego Medical, LLC
Keystone Heart
Medtronic
Metactive Medical
Boston Scientific Corporation
Innovative Cardiovascular Solutions, LLC.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

Embolic protection devices market was valued at USD 1.4 billion in 2022 and is poised to exhibit over 8.5% CAGR from 2023 to 2032 owing to the rising prevalence of cardiovascular diseases (CVDs) globally.

The embolic protection devices market from the distal filters segment is estimated to grow at above 8.5% CAGR over 2023-2032 and is expected to generate USD 1.9 billion by 2032 driven by the availability of a wide range of specifications and the surging usage of distal filters.

North America amassed over 35.5% share of the embolic protection devices market in 2022 and is foreseen to be valued at USD 1 billion by 2032 attributed to the rising prevalence of cardiovascular and neurovascular diseases in the region.

Some of the top players engaged in the industry are Transverse Medical, Inc., Abbott Laboratories, Cardinal Health, Allium Medica, Edwards Lifesciences Corporation, W. L. Gore & Associates (Gore Medical), Contego Medical, LLC, Keystone Heart, Medtronic, Metactive Medical, Boston Scientific Corporation, and Innovative Cardiovascular Solutions, LLC.